AI assistant
Sending…
Bio Green Med Solution, Inc. — Director's Dealing 2020
Dec 21, 2020
35092_dirs_2020-12-21_32f199a6-a86c-4c81-a0da-0a67776600fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2020-12-17
Reporting Person: SCHWARTZ BRIAN (Director)
More from Bio Green Med Solution, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 13
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 12
Registration Form
2025
Nov 28
Annual Report
2025
Nov 26
Director's Dealing
2025
Nov 14
Director's Dealing
2025
Nov 14
Major Shareholding Notification
2025
Nov 14
Interim / Quarterly Report
2025
Nov 13